Literature DB >> 492353

Transient apnoea after systemic injection of GABA in the rat.

P Holzer, K Hagmüller.   

Abstract

1. I. v. or i.a. injection of GABA produced a transient apnoea in rats under pentobarbital anaesthesia. The dose-response relationship and specifity of this effect were investigated. 2. Injection of GABA into the femoral vein led to an apnoea of dose-dependent duration, the dose-response curve showed an ED50 of about 5 mumoles GABA kg-1 and a maximum duration of about 8 s. 3. The depressant action of systemic GABA on respiration seems to be specific as only close structural analogues of GABA such as trans-4-aminocrotonic acid, beta-hydroxy-GABA, delta aminovaleric acid, beta-alanine, and taurine were able to mimic the action of GABA. 4. Injection of these structural analogues of GABA 15 s rior to an injection of GABA inhibited the respiratory depressant effect of GABA dose-dependently. Picrotoxin also antagonized the apnoic action of GABA. 5. The results indicate that the apnoea induced by systemic injection of GABA is mediated by an action on GABA receptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 492353     DOI: 10.1007/bf00499719

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  PRESYNAPTIC AND POSTSYNAPTIC EFFECTS OF INHIBITORY DRUGS ON THE CRAYFISH NEUROMUSCULAR JUNCTION.

Authors:  J DUDEL
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1965-03-18

2.  The effect of gamma-aminobutyric acid on blood pressure.

Authors:  H TAKAHASHI; M TIBA; M IINO; T TAKAYASU
Journal:  Jpn J Physiol       Date:  1955-12-15

3.  Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation.

Authors:  G A Johnston; D R Curtis; P M Beart; C J Game; R M McCulloch; B Twitchin
Journal:  J Neurochem       Date:  1975-01       Impact factor: 5.372

4.  Effects of amino acid compounds injected into cerebrospinal fluid spaces, on colonic temperature, arterial blood pressure and behaviour of the rat.

Authors:  G Sgaragli; F Pavan
Journal:  Neuropharmacology       Date:  1972-01       Impact factor: 5.250

5.  Autoradiographic investigation of the distribution of [14C]GABA in tissues of normal and aminooxyacetic acid-treated mice.

Authors:  W Hespe; E Roberts; H Prins
Journal:  Brain Res       Date:  1969-08       Impact factor: 3.252

6.  Blood-brain barrier to H3-gamma-aminobutyric acid in normal and amino oxyacetic acid-treated animals.

Authors:  K Kuriyama; P Y Sze
Journal:  Neuropharmacology       Date:  1971-01       Impact factor: 5.250

7.  Actions of gamma-aminobutyric acid on sympathetic ganglion cells.

Authors:  P R Adams; D A Brown
Journal:  J Physiol       Date:  1975-08       Impact factor: 5.182

8.  Facilitatory and inhibitory effects of gamma-aminobutyric acid on ganglionic transmission in the sympathetic cardiac nerves of the dog.

Authors:  T Kimura; H Imamura; K Hashimoto
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

9.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

Authors:  S R Zukin; A B Young; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

10.  Gamma-aminobutyric acid(GABA) uptake by the developing mouse brain in vivo.

Authors:  G Levi; P Amaldi; G Morisi
Journal:  Brain Res       Date:  1972-06-22       Impact factor: 3.252

View more
  3 in total

1.  GABA transport in the rat thyroid.

Authors:  H Gebauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

2.  Central respiratory and cardiovascular effects in the rat of some putative neurotransmitter amino acids.

Authors:  P Wessberg; J Hedner; T Hedner; J Jonason
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

3.  Respiratory effects of gamma-hydroxybutyric acid in anesthetized rats.

Authors:  J Hedner; J Jonason; D Lundberg
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.